Inflammation Trend Tables
Purpose
The purpose of this section is to document the changes in inflammatory markers over time and provide a clear visual representation of the transition from severe systemic inflammation in 2021 to the current state of inflammatory control.
The primary inflammatory markers reviewed are:
- C-Reactive Protein (CRP)
- Erythrocyte Sedimentation Rate (ESR)
These markers are especially important because inflammation was the defining health challenge during the 2021 period of severe illness.
Table 1 — C-Reactive Protein (CRP) Trend
| Date | Laboratory | CRP Result | Interpretation |
|---|---|---|---|
| October 2021 | Laboratory Testing | 32 mg/L | Severe systemic inflammation |
| 2022 | Follow-up Testing | Improved | Recovery phase |
| June 2024 | Labcorp | 2 mg/L | Low inflammatory activity |
| November 2024 | Labcorp | 1 mg/L | Excellent inflammatory control |
| June 2026 | Function Health / Quest | Very low | No evidence of active inflammation |
CRP Trend Summary
The CRP trend demonstrates one of the clearest improvements documented in the Health Inventory.
2021
CRP of 32 mg/L indicated a significant inflammatory response.
This occurred with:
- Severe decline in health.
- Elevated ESR.
- Normocytic anemia.
- Significant systemic symptoms.
2024–2026
CRP decreased to very low levels.
Current interpretation:
✓ Inflammatory activity greatly improved.
✓ No laboratory evidence of ongoing systemic inflammation.
✓ Continued monitoring appropriate because of autoimmune history.
Table 2 — Erythrocyte Sedimentation Rate (ESR) Trend
| Date | Laboratory | ESR Result | Interpretation |
|---|---|---|---|
| October 2021 | Laboratory Testing | 71 mm/hr | Severe inflammatory response |
| 2022 | Follow-up Testing | Improved | Recovery phase |
| September 2023 | Laboratory Testing | 27 mm/hr | Improved inflammatory status |
| June 2026 | Function Health / Quest | 6 mm/hr | Excellent inflammatory control |
ESR Trend Summary
The ESR trend mirrors the CRP improvement.
The reduction from:
71 mm/hr → 6 mm/hr
represents a significant objective measure of recovery.
Current interpretation:
✓ No evidence of active systemic inflammation.
✓ Previous inflammatory illness appears resolved.
✓ Continued observation appropriate because autoimmune markers remain present.
Table 3 — Combined Inflammation Trend Summary
| Time Period | CRP | ESR | Health Status |
|---|---|---|---|
| 2021 | 32 | 71 | Severe inflammatory illness |
| 2022 | Improving | Improving | Recovery phase |
| 2023 | Improved | 27 | Continued recovery |
| 2024 | 1–2 | — | Low inflammatory state |
| 2026 | Very low | 6 | Excellent inflammatory control |
Overall Inflammation Assessment
The laboratory trend demonstrates a clear progression:
Phase 1 — Active Inflammation (2021)
Findings:
- CRP elevated.
- ESR elevated.
- Anemia present.
- Significant decline in health.
Phase 2 — Recovery (2022–2023)
Findings:
- Inflammatory markers decreased.
- Blood counts began improving.
- Extensive evaluation performed.
Phase 3 — Inflammatory Control (2024–2026)
Findings:
- CRP remains very low.
- ESR normal.
- Blood counts recovered.
- No evidence of active systemic inflammation.
Clinical Significance
The inflammation trend is one of the strongest indicators of recovery in the Health Inventory.
The overall conclusion is:
The severe systemic inflammatory state documented in 2021 has resolved, with current laboratory evidence demonstrating excellent inflammatory control. Persistent autoimmune markers remain an area for monitoring but are not accompanied by current evidence of active inflammation.
Related Sections
This trend table connects directly with:
- Section 3.7 — History of Systemic Inflammatory Illness
- Section 3.6 — Autoimmune Serology
- Section 7.2.1 — Inflammation Trends
- Section 7.2.2 — Autoimmune Trends
- Section 7.3.2 — Blood Health Trend Tables
- Section 8 — Physician Consultation Summaries
Navigation
Previous Section: Section 7.3 — Longitudinal Trend Tables Index
Current Section: Section 7.3.1 — Inflammation Trend Tables
Next Section: Section 7.3.2 — Blood Health Trend Tables
Return to Section 7 — Laboratory Archive
Anchor My Faith 